In 2025, the treatment of wide-neck brain aneurysms has been revolutionized by a "scaffolding" technique that uses liquid embolic agents in conjunction with micro-stents. In this procedure, a stent is first placed across the opening of the aneurysm to act as a barrier, and then a liquid embolic is injected into the aneurysm sac. The liquid fills every corner of the bulge, creating a solid cast that prevents blood from entering and potentially causing a rupture. This dual approach provides a more stable and permanent solution than coils alone, which can sometimes compact over time and leave the aneurysm at risk.

The increased efficacy of these combined treatments is a major growth area for the Liquid Embolic Market, as clinical trials show a lower rate of aneurysm recurrence. Patients treated with this method in 2025 often require fewer follow-up procedures, making it a cost-effective choice for long-term health management. As the viscosity of these liquid agents is further refined, surgeons can now treat even the most irregularly shaped aneurysms with high confidence.

FAQ

Q: Is this procedure safer than "clipping" an aneurysm? A: For many patients, this endovascular approach is safer because it does not require opening the skull, leading to much shorter recovery times.

Q: Can the liquid embolic leak out of the aneurysm? A: In 2025, surgeons use temporary balloons or permanent stents to keep the liquid contained within the aneurysm sac until it hardens.